10 Data Quality, Sampling, QA/QC, and Procedures for Biological EMDs

EMDs can provide unique information about biological activityRefers to when a microorganism performs a specific function (e.g., sulfate reduction, metabolism of benzene) at a site that can be used along with other lines of evidence to support decision making. In most cases, no formal standardized methods exist for the EMD technologies described in this document because the science of EMDs is developing rapidly. However, some common methodologies can contribute to the successful description of microbial activity at a site using EMDs. For instance, quality control procedures for CSIA are similar to procedures for traditional chemical analytical techniques and are detailed in Section 3.3. This section focuses on biological and biochemical EMDs. These EMDs are also referred to as molecular biological techniques (MBTs).

10.1 Basic Concepts

USEPA defines data quality as: “A measure of the degree of acceptability or utility of data for a particular purpose” (USEPA 2002b). Acceptability and utility are determined by sampling design and execution, as well as by laboratory practices. Some common approaches contribute to the successful qualitative description and quantitative measurement of site biological properties. This section describes the critical components of EMD approaches so that project managers can make informed decisions in the design of effective sampling plans. Using the guidance presented here, regulators can also evaluate those plans, and stakeholders can evaluate the quality of vendors’ EMD analyses and data.

10.2 Project Life Cycle Stages

EMD sampling can occur at any point in the project life cycle: site characterization, remediation, monitoring, or closure. Therefore, quality considerations are critical in the remedial investigation (RI)/site assessment, feasibility study (FS)/corrective action planning, site monitoring, and closure request processes. General guidelines for sampling and QA/QC procedures will not vary between the different phases of the project life cycle, and Sections 10.3 through 10.14 are applicable regardless of life cycle phase. Some considerations specific to individual project phases are discussed in Section 10.15.

10.3 Sampling Plan

The collection of quality data begins prior to field or laboratory sampling. The hypothesis to be tested must be carefully considered and a plan which addresses that hypothesis formed.

10.3.1 Number of Samples

10.3.2 Sample Locations

10.3.3 Sampling Design Summary

Table 10-1 presents a summary of sampling design considerations.

10.4 Sampling

Biomass in environmental matrices can be collected in a variety of ways for EMD analysis. This section discusses general considerations for EMD sampling, the application of active and passive approaches, as well techniques specific to different matrices. Health and safety considerations for EMD sampling are similar to soil and groundwater sampling for conventional parameters and should be included in the site health and safety plan.

10.4.1 Aseptic Sampling and Sterility

10.4.2 Active Groundwater Sampling

10.4.3 Passive Groundwater Sampling

10.4.4 Soil Sampling

10.4.5 Sampling Devices

10.5 Sample Preservation

Sample preservation conditions upon receipt at the laboratory should be reported with any EMD analytical shipment. Sample preservation is critical for EMD analysis, as it is for chemical analysis. The approach to sample preservation depends on whether the material analyzed is DNA, RNA or whole cells (microbial activity).

10.5.1 DNA

10.5.2 RNA

10.5.3 Whole cells

10.6 Complementary Traditional Site Characterization Data

Site specific data determined by more traditional analytical techniques are essential to interpretation of EMD results. EMD results that are consistent with site understanding based on traditional analytical techniques increases confidence in EMD data quality and appropriate technique selection. The traditional parameters that aid in interpretation of EMD data include site specific geology, hydrogeology, biogeochemistry, and water chemistry, as well as concentration trends for the contaminant.

10.7 Method QA/QC

In the field, current practices recommend, but do not require, data quality samples such as field blanks, equipment blanks, matrix blanks, and trip blanks. The inconsistent use of data quality samples creates problems in identifying erroneous data, such as samples affected by cross contamination or deterioration during shipping.

Of the biological EMDs, only PCR-based methods have USEPA guidance related to laboratory quality: “Quality Assurance/Quality Control Guidance for Laboratories Performing PCR Analyses on Environmental Samples” (USEPA 2004a). This document provides a good example of a detailed QA analysis for a particular laboratory method. The document’s guidance could be extrapolated to those laboratories performing qPCR for environmental remediation applications. When considering those EMDs not based on PCR, this document still provides many meaningful QA/QC considerations. Additional QA/QC guidance can be obtained from the USEPA qPCR method for Enterococci: “Method A: Enterococci in Water by TaqMan® Quantitative Polymerase Chain Reaction (qPCR) Assay” (USEPA 2010).

10.8 Known Biases (Extractions, PCR, Microbial Ecology)

Bias is a measure of agreement or disagreement between the concentration of an analyte as measured by a method and the true concentration in the environmental sample. Each EMD may have biases specific to the methodology. Please refer to the individual EMD sections for discussion of these biases. Because DNA extraction and amplification support several of the EMDs, some common biases are presented here.

10.9 Blanks/Contamination Controls

Laboratory procedures can inadvertently introduce the substance to be detected into an otherwise uncharacterized sample. Such contamination, sometimes referred to as “cross contamination”, is of particular concern in DNA-based methods due to their sensitivity. Cross contamination is also a problem in methods involving live cells due to the possibility that those cells may replicate during transport and handling or that cells may lyse and have their cellular contents degraded (e.g., via the action of nucleases).

The ability to evaluate a blank and reference control is a critical QC criterion for all methods, and the extent to which the blank has followed the path of the uncharacterized sample can make results more convincing. Blanks should be reported with any analytical batch.

10.10 Positive Controls

A positive control shows that, in the presence of the substance to be analyzed, the test returns a positive result. Positive controls provide one indication that the test or measurement is working properly and can be relied on to detect the presence of a substance and potentially a measure of its quantity. This approach can be either qualitative or quantitative to evaluate the procedures employed. Positive controls should be reported with any analytical batch. Data from analyses where any positive control fails should be discarded. As an example, positive controls for qPCR should include a qPCR amplification positive (a DNA source that can be amplified by the same primer as the target sequence, analogous to a known concentration gas chromatography standard), and matrix spike samples.

10.11 Negative Controls

A negative control shows that, in the absence of the substance to be analyzed, the test returns a negative result. Negative controls provide another indication that the test or measurement is working properly and can be relied on to provide a negative result or measurement of non-detect in the absence (or presence at a concentration below the detection limit) of a substance. Negative controls should be reported with any analytical batch. Data from analyses where any negative control fails should be discarded. As an example, negative controls for qPCR should include a DNA extraction negative (DNA-free water) and a qPCR amplification negative.

10.12 QA Metrics for Qualitative Analyses

The key metrics of qualitative analyses are the rates of false positives and false negatives. As a laboratory conducts positive and negative controls for a given analysis, it should track the rate at which those controls indicate the analysis has failed. In controlled laboratory conditions, these rates should be low, but they should be measurable. These rates should be available on request from the analytical laboratory.

The false positive and false negative rates may be used to estimate the number of results needed to confirm an initial result at a predetermined level of confidence. For example, if the combined false positive and false negative rates total 10%, multiple analyses should be required in order to reach a pre-determined confidence of 0.05 (5%).

10.13 QA Metrics for Quantitative Analyses

The acceptability and utility of quantitative analyses are routinely evaluated according to several standard measures. This section discusses how to apply the standard measures of precision, accuracy, completeness, representativeness, comparability, and sensitivity to EMDs.

10.14 Reporting

Data from any analysis must be communicated in a manner that not only expresses the results of an analysis but also provides adequate supporting information to determine the acceptability and usability of the result. Where possible, EMDs should meet the same conceptual data quality standards as other environmental analyses.

10.15 Project Life Cycle Specific Considerations

EMDs can improve site management at several points in the project life cycle. Any point where questions are raised regarding the site biological activity, EMDs should be considered.

10.15.1 Site Characterization

10.15.2 Remediation

10.15.3 Monitoring

10.15.4 Closure

10.16 Specialized Application Consideration

EMDs may also answer site-specific questions that do not fit in the preceding sections.

10.17 Summary

The absence of standard methods for analysis of molecular EMD tools necessitates strict adherence to a rigorous QA/QC plan. Success of an EMD application will depend on several factors, including the following:

  1. development of a site specific sampling plan for spatial extent and frequency that is developed in response to project goals
  2. use of appropriate sampling methodologies, including selection of active or passive sampling, preventing sample contamination, and sample handling practices that preserve the microorganisms or nucleic acids depending on the selected EMD
  3. appropriate use of blank, control and duplicate samples to provide controls of sources of error in sampling and analysis
  4. adaptation of sampling and EMD tool selection to the site project life cycle

Permission is granted to refer to or quote from this publication with the customary acknowledgment of the source (see suggested citation and disclaimer).

 

This web site is owned by ITRC.

1250 H Street, NW • Suite 850 • Washington, DC 20005 | P: (202) 266-4933 • F: (202) 266-4937

Terms of Service, Privacy Policy, and Usage Policy

 

ITRC is sponsored by the Environmental Council of the States